Dr. Eric Marsh, MD, PhD
Claim this profileChildren's Hospital of Philadelphia
Studies Arterial Tortuosity Syndrome
Studies Rett Syndrome
6 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Eric Marsh, MD, PhD is currently running
EPX-100
for Dravet Syndrome
The purpose of this study is to evaluate the safety and efficacy of EPX-100 as adjunctive therapy in participants with Dravet syndrome.
Recruiting0 awards Phase 29 criteria
TSHA-102
for Rett Syndrome
The REVEAL Pediatric Study is a multi-center, Phase 1/2 open-label, dose-escalation and dose-expansion study of TSHA-102, an investigational gene therapy, in pediatric females with Rett Syndrome. The safety, tolerability, and preliminary efficacy of two dose levels will be evaluated. The study duration is up to 6 years.
Recruiting1 award Phase 1 & 24 criteria
More about Eric Marsh, MD, PhD
Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Eric Marsh, MD, PhD has experience with
- Soticlestat
- Ketamine
- Clemizole Hydrochloride
- TSHA-102
- Placebo
Breakdown of trials Eric Marsh, MD, PhD has run
Arterial Tortuosity Syndrome
Rett Syndrome
Dravet Syndrome
Lennox Gastaut Syndrome
Rett syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eric Marsh, MD, PhD specialize in?
Eric Marsh, MD, PhD focuses on Arterial Tortuosity Syndrome and Rett Syndrome. In particular, much of their work with Arterial Tortuosity Syndrome has involved MECP2 positive patients, or patients who are undergoing treatment.
Is Eric Marsh, MD, PhD currently recruiting for clinical trials?
Yes, Eric Marsh, MD, PhD is currently recruiting for 3 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Eric Marsh, MD, PhD has studied deeply?
Yes, Eric Marsh, MD, PhD has studied treatments such as Soticlestat, Ketamine, Clemizole Hydrochloride.
What is the best way to schedule an appointment with Eric Marsh, MD, PhD?
Apply for one of the trials that Eric Marsh, MD, PhD is conducting.
What is the office address of Eric Marsh, MD, PhD?
The office of Eric Marsh, MD, PhD is located at: Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104 United States. This is the address for their practice at the Children's Hospital of Philadelphia.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.